Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ODM-212 by Orion for Solid Tumor: Likelihood of Approval
ODM-212 is under clinical development by Orion and currently in Phase II for Solid Tumor. According to GlobalData, Phase II...